Dupracetam

Dupracetam is a nootropic drug from the racetam family.[1][2]

Dupracetam

Clinical data
ATC code	none
Legal status
Legal status	In general: unscheduled
Identifiers
IUPAC name 2-(2-oxopyrrolidin-1-yl)-N'-[2-(2-oxopyrrolidin-1-yl)acetyl]acetohydrazide
CAS Number	59776-90-8
PubChem CID	68793
ChemSpider	62033
UNII	BVM2UGN450
ChEMBL	ChEMBL2104359
CompTox Dashboard (EPA)	DTXSID40975187
ECHA InfoCard	100.056.279
Chemical and physical data
Formula	C12H18N4O4
Molar mass	282.300 g·mol^−1
3D model (JSmol)	Interactive image
SMILES C1CC(=O)N(C1)CC(=O)NNC(=O)CN2CCCC2=O
InChI InChI=1S/C12H18N4O4/c17-9(7-15-5-1-3-11(15)19)13-14-10(18)8-16-6-2-4-12(16)20/h1-8H2,(H,13,17)(H,14,18) Key:YPUPYVWSTBYCBY-UHFFFAOYSA-N
(what is this?)  (verify)

One of its metabolites, 1-Methylhydantoin, displays renal toxicity in high doses.[3]

See also

• Piracetam

References

1. Dell HD, Jacobi H, Kamp R, Kurz J, Wünsche C (August 1981). "[1-Methylhydantoin, an unexpected metabolite of the intelligence-affecting substance dupracetam (author's transl)]". Archiv der Pharmazie (in German). 314 (8): 697–702. doi:10.1002/ardp.19813140808. PMID 7294979.
2. Hall ED, Von Voigtlander PF (November 1987). "Facilitatory effects of piracetam on excitability of motor nerve terminals and neuromuscular transmission". Neuropharmacology. 26 (11): 1573–9. doi:10.1016/0028-3908(87)90003-7. PMID 2829047.
3. Yang, B.; Liu, D.; Li, C.; Liu, F.; Peng, Y.; Jiang, Y. (2007). "1-Methylhydantoin Cytotoxicity on Renal Proximal Tubular Cells in Vitro". Renal Failure. 29 (8): 1025–1029. doi:10.1080/08860220701641272. PMID 18067051.